Company Tobira Therapeutics Inc Nasdaq
Equities
US75874Q1076
Biotechnology & Medical Research
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 53 | - |
Scott Reents
DFI | Director of Finance/CFO | 57 | - |
Corporate Secretary | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,821,231 | 18,577,505 ( 98.71 %) | 0 | 98.71 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |